Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic interventionEkta Shirbhate, Harish Rajak|Pharmacological Reports|2021Cited by 145
Furan and benzofuran derivatives as privileged scaffolds as anticancer agents: SAR and docking studies (2010 to till date)Preeti Patel, Harish Rajak, Ruchi Shakya et al.|Journal of Molecular Structure|2023Cited by 60
Panobinostat as Pan-deacetylase Inhibitor for the Treatment of Pancreatic Cancer: Recent Progress and Future ProspectsAvineesh Singh, Harish Rajak, Vijay K. Patel et al.|Oncology and Therapy|2016Cited by 41
The Safety, Efficacy and Therapeutic Potential of Histone Deacetylase Inhibitors with Special Reference to Panobinostat in Gastrointestinal Tumors: A Review of Preclinical and Clinical StudiesAvineesh Singh, Harish Rajak, Preeti Patel et al.|Current Cancer Drug Targets|2018Cited by 25
Pharmacophore Based 3D-QSAR, Virtual Screening and Docking Studies on Novel Series of HDAC Inhibitors with Thiophen Linker as Anticancer AgentsPreeti Patel, Harish Rajak, Avineesh Singh et al.|Combinatorial Chemistry & High Throughput Screening|2016Cited by 22